Entry |
|
Symbol |
PPP3CC
|
Name |
(RefSeq) serine/threonine-protein phosphatase 2B catalytic subunit gamma isoform isoform X1
|
KO |
K04348 | serine/threonine-protein phosphatase 2B catalytic subunit [EC:3.1.3.16] |
|
Organism |
ccad Cervus canadensis (wapiti)
|
Pathway |
ccad04625 | C-type lectin receptor signaling pathway |
ccad04650 | Natural killer cell mediated cytotoxicity |
ccad05022 | Pathways of neurodegeneration - multiple diseases |
ccad05166 | Human T-cell leukemia virus 1 infection |
ccad05167 | Kaposi sarcoma-associated herpesvirus infection |
ccad05170 | Human immunodeficiency virus 1 infection |
ccad05235 | PD-L1 expression and PD-1 checkpoint pathway in cancer |
|
Brite |
KEGG Orthology (KO) [BR:ccad00001]
09130 Environmental Information Processing
09132 Signal transduction
04010 MAPK signaling pathway
122431708 (PPP3CC)
04310 Wnt signaling pathway
122431708 (PPP3CC)
04370 VEGF signaling pathway
122431708 (PPP3CC)
04020 Calcium signaling pathway
122431708 (PPP3CC)
04022 cGMP-PKG signaling pathway
122431708 (PPP3CC)
09140 Cellular Processes
09143 Cell growth and death
04114 Oocyte meiosis
122431708 (PPP3CC)
04218 Cellular senescence
122431708 (PPP3CC)
09150 Organismal Systems
09151 Immune system
04625 C-type lectin receptor signaling pathway
122431708 (PPP3CC)
04650 Natural killer cell mediated cytotoxicity
122431708 (PPP3CC)
04660 T cell receptor signaling pathway
122431708 (PPP3CC)
04658 Th1 and Th2 cell differentiation
122431708 (PPP3CC)
04659 Th17 cell differentiation
122431708 (PPP3CC)
04662 B cell receptor signaling pathway
122431708 (PPP3CC)
09152 Endocrine system
04922 Glucagon signaling pathway
122431708 (PPP3CC)
04921 Oxytocin signaling pathway
122431708 (PPP3CC)
04924 Renin secretion
122431708 (PPP3CC)
09156 Nervous system
04724 Glutamatergic synapse
122431708 (PPP3CC)
04728 Dopaminergic synapse
122431708 (PPP3CC)
04720 Long-term potentiation
122431708 (PPP3CC)
09158 Development and regeneration
04360 Axon guidance
122431708 (PPP3CC)
04380 Osteoclast differentiation
122431708 (PPP3CC)
09160 Human Diseases
09161 Cancer: overview
05235 PD-L1 expression and PD-1 checkpoint pathway in cancer
122431708 (PPP3CC)
09172 Infectious disease: viral
05166 Human T-cell leukemia virus 1 infection
122431708 (PPP3CC)
05170 Human immunodeficiency virus 1 infection
122431708 (PPP3CC)
05163 Human cytomegalovirus infection
122431708 (PPP3CC)
05167 Kaposi sarcoma-associated herpesvirus infection
122431708 (PPP3CC)
09171 Infectious disease: bacterial
05152 Tuberculosis
122431708 (PPP3CC)
09164 Neurodegenerative disease
05010 Alzheimer disease
122431708 (PPP3CC)
05014 Amyotrophic lateral sclerosis
122431708 (PPP3CC)
05020 Prion disease
122431708 (PPP3CC)
05022 Pathways of neurodegeneration - multiple diseases
122431708 (PPP3CC)
09165 Substance dependence
05031 Amphetamine addiction
122431708 (PPP3CC)
09166 Cardiovascular disease
05417 Lipid and atherosclerosis
122431708 (PPP3CC)
09180 Brite Hierarchies
09181 Protein families: metabolism
01009 Protein phosphatases and associated proteins [BR:ccad01009]
122431708 (PPP3CC)
Enzymes [BR:ccad01000]
3. Hydrolases
3.1 Acting on ester bonds
3.1.3 Phosphoric-monoester hydrolases
3.1.3.16 protein-serine/threonine phosphatase
122431708 (PPP3CC)
Protein phosphatases and associated proteins [BR:ccad01009]
Protein serine/threonine phosphatases
Phosphoprotein phosphatases (PPPs)
Calcineurin (PPP3/ PP2B)
Catalytic subunits
122431708 (PPP3CC)
|
SSDB |
|
Motif |
|
Other DBs |
|
LinkDB |
|
Position |
30:2766213..2847530
|
AA seq |
531 aa
MSGRNLHLSTTERVIKAVPFPPTQRLTLKEVFENGKPKIDVLKNHLVKEGRLEEEVALKI
INDGAAILRQEKTMIEVDAPITVCGDIHGQFFDLMKLFEVGGSPSNTRYLFLGDYVDRGY
FSIECVLYLWSLKINHPKTLFLLRGNHECRHLTEYFTFKQECRIKYSEQVYDACMETFDC
LPLAALLNQQFLCVHGGMSPEITCLDDIRKLDRFKEPPAFGPVCDLLWSDPSEDYGSEKT
LEHYTHNTVRGCSYFYSYPAVCEFLQNNNLLSIIRAHEAQDAGYRMYRKSQTTGFPSLIT
IFSAPNYLDVYNNKAAVLKYENNVMNIRQFNCSPHPYWLPNFMDVFTWSLPFVGEKVTEM
LVNILNICSDDELISDDELEDHYISSFQKGGTTVRKEIIKNKIRAIGKMARVFSILREES
ESVLTLKGLTPTGTLPLGVLSGGKQTIETATVEAVEAREAIRGFSLQHRIRSFEEARGLD
RINERMPPRKDSQYFDGPVKLVQANATHRSDKGRRASNDSESCGGTGGSKT |
NT seq |
1596 nt +upstreamnt +downstreamnt
atgtccgggaggaacctccacctctccaccaccgaacgcgtcatcaaagctgtccccttt
cctccgacccagcggcttactttgaaggaagtatttgagaatgggaaacctaaaattgat
gttttgaaaaaccatttggtgaaggaagggcgactggaagaggaagtagccttaaaaata
atcaatgatggggctgccatactgagacaagagaagactatgatagaagtagacgctcca
atcacggtatgtggtgacattcatggacagttctttgacctgatgaagttgtttgaagtt
ggagggtcgcctagtaatacacgctacctctttctgggtgactatgtggacagaggttat
ttcagtatagagtgtgtgctgtatttatggagtttaaagatcaatcatcccaaaacattg
tttctgcttcgaggaaatcatgaatgcaggcatcttacagaatattttaccttcaaacag
gaatgtcgaatcaaatattctgaacaggtgtacgatgcatgtatggaaacatttgactgt
cttcctcttgctgccctcttaaaccagcagtttctgtgtgtacatggaggaatgtcacct
gaaattacttgtttagatgacattcggaaattagacaggtttaaagaacctccagccttt
gggccagtatgtgacctgctttggtctgatccctcggaggattatggcagtgaaaagacc
ttggaacactacacccacaacactgtccgagggtgttcttatttttacagttaccctgca
gtttgtgaatttctgcagaacaataatttgctctcaataatcagagcccatgaagcccaa
gatgccgggtaccgaatgtataggaagagccaaacgacgggctttccatcgctcattacg
attttctctgcacccaattacctcgatgtctataacaacaaagctgctgtgttaaaatat
gaaaacaacgtcatgaatatcaggcagtttaactgttctccacacccttactggcttcca
aacttcatggatgttttcacgtggtctttgccatttgttggggaaaaagtcacagagatg
ctggttaacattctcaacatatgctctgatgatgaattgatttctgatgatgaacttgaa
gatcactacatttcaagctttcagaaaggaggcactaccgtccgcaaggagatcatcaag
aataaaatcagagctattgggaagatggcacgggtcttttcaattcttcgggaagagagt
gagagtgtgctaactctcaagggcctgactcctacggggacactccctttgggtgtcctc
tcaggaggaaagcagaccattgagacagccacagtagaagcggtagaggcccgggaagcc
atcagagggttttcgcttcagcacaggatccggagttttgaagaagcccgaggtctggac
cgaattaatgagcggatgccaccccgcaaagatagccagtactttgatgggccggtgaaa
ctggtccaagccaatgctactcacaggagcgacaagggaagaagagccagtaatgactca
gagtcctgtggtggcactggtggatccaagacctaa |